Müller F
Z Hautkr. 1983 Dec 1;58(23):1689-708.
For demonstration of treponemal IgM antibodies in sera and CSF taken from 56 syphilitic patients with or without involvement of the CNS in the infection, comparative studies have been performed making use of the 19S(IgM)-FTA-ABS test and a TP-IgM-ELISA. Compared with the 19S(IgM)-FTA-ABS, the TP-IgM-ELISA has a specificity of 97% and a sensitivity of 93%. With regard to qualitative investigation of serum samples, both tests showed nearly equivalent results. In 10 out of 16 CSF samples taken from patients with untreated neurosyphilis, a treponemal IgM antibody could be proved by TP-IgM-ELISA. According to these findings, this assay seems to be a reliable test system for demonstration of treponemal IgM antibodies not only in serum but also in CSF.
为了检测56例梅毒患者(无论中枢神经系统是否受累)血清和脑脊液中的梅毒螺旋体IgM抗体,利用19S(IgM)-FTA-ABS试验和TP-IgM-ELISA进行了对比研究。与19S(IgM)-FTA-ABS相比,TP-IgM-ELISA的特异性为97%,敏感性为93%。在血清样本的定性检测方面,两种检测方法的结果几乎相同。在16例未经治疗的神经梅毒患者的脑脊液样本中,有10例通过TP-IgM-ELISA检测出梅毒螺旋体IgM抗体。根据这些结果,该检测方法似乎是一种可靠的检测系统,不仅可用于检测血清中的梅毒螺旋体IgM抗体,也可用于检测脑脊液中的该抗体。